FFA
VYGR icon

Frazier Financial Advisors’s Voyager Therapeutics VYGR Stock Holding History

Frazier Financial Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-255
Closed -$1.49K – 885
2024
Q3 		$1.49K Buy
255
+99
+63% +$720 ﹤0.01% 730
2024
Q2 		$1.23K Hold
156
– – ﹤0.01% 844
2024
Q1 		$1.45K Buy
156
+40
+34% +$338 ﹤0.01% 775
2023
Q4 		$980 Buy
+116
New +$841 ﹤0.01% 761

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frazier Financial Advisors's VYGR Position: Q4 2024 in Review

Frazier Financial Advisors sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 255 shares — an estimated $1.49K sold.

Frazier Financial Advisors first reported a position in VYGR in Q4 2023 and held it in 4 quarters. The position peaked at $1.49K in Q3 2024. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.

  • Frazier Financial Advisors reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 255 Voyager Therapeutics shares in Q4 2024, an estimated $1.49K.
  • Frazier Financial Advisors first reported a position in Voyager Therapeutics in Q4 2023 and held it in 4 quarters.
  • Frazier Financial Advisors's Voyager Therapeutics position peaked at $1.49K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.

Based on Frazier Financial Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.